导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.43% | 2314/4773 |
| 近一周 | -1.11% | 333/5462 |
| 近一月 | 1.45% | 342/5421 |
| 近一季 | 1.53% | 535/5209 |
| 近半年 | -3.18% | 2144/4920 |
| 近一年 | 0.91% | 2449/4366 |
| 近两年 | 32.11% | 2197/2954 |
| 近三年 | 34.81% | 874/2253 |
| 成立以来 | 77.00% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.51% 1524/4961 |
-8.75% 3914/5312 |
- - |
- - |
| 2025 | 11.41% 2748/4813 |
1.09% 1703/3635 |
6.50% 444/4076 |
0.46% 3899/4524 |
3.02% 780/4813 |
| 2024 | 26.64% 217/3463 |
6.09% 313/2808 |
6.48% 160/3014 |
9.53% 2692/3129 |
2.35% 955/3463 |
| 2023 | 7.44% 144/2656 |
6.75% 650/2280 |
3.30% 100/2385 |
1.70% 286/2515 |
-4.20% 907/2655 |
| 2022 | 1.40% 33/2207 |
0.81% 109/1919 |
1.98% 1389/2016 |
-6.30% 101/2113 |
5.26% 477/2208 |
| 2021 | 14.10% 342/1822 |
4.85% 133/1255 |
-0.30% 1139/1330 |
6.27% 235/1466 |
2.71% 532/1822 |
| 2020 | -4.89% 965/1250 |
-12.35% 883/1028 |
2.47% 971/1067 |
4.88% 941/1164 |
0.97% 1046/1184 |
| 2019 | - - |
- - |
- - |
- - |
4.88% 769/918 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 景顺长城沪港深红利成长低波指数C VS. 长安沪深300非周期A(740101) |